Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University
Retrieved on:
수요일, 5월 15, 2024
Wyss Institute, Synthetic biology, Nature, Biochemistry, Fats, Human, Triglyceride, Palm oil, Research, Regeneration, Nangle, Applied science, Food, Carbon, Harvard University, Sugar, Circe, Harvard Medical School, HMS, Plastics industry, CO2, Hospital, Wyss, Silver, Biofuel, Electricity, Oil, OTD, Systems biology, Water, Plant, Renewable energy
Developed in the lab of Wyss Core Faculty member Pamela Silver, Ph.D., Circe’s technology grows microbes on gasses like carbon dioxide --- in the same way plants grow --- and harvests the molecules they build. Nangle and Ziesack used synthetic biology to tweak the metabolisms of certain microbes that naturally “eat” greenhouse gasses so that they use those gases to manufacture molecules that are valuable to many industries. Their platform has produced molecules identical to those that make up sugars, fats, biodegradable plastics, and biofuels, all using only CO2, water, and electricity as inputs.
Key Points:
- Circe has raised more than $8 million to date from investors including Regen Ventures, Undeterred Capital, Ponderosa Ventures, Bee Partners, and Elementum Ventures.
- “One of the great challenges humanity faces is how to maintain global growth and production and decarbonize everything at the same time.
- Circe is addressing this critical problem by using gas fermentation to manufacture the products and molecules we need in a carbon-negative way,” said Shannon Nangle , Ph.D., who co-founded Circe along with fellow Wyss member Marika Ziesack , Ph.D.
- Developed in the lab of Wyss Core Faculty member Pamela Silver , Ph.D., Circe’s technology grows microbes on gasses like carbon dioxide --- in the same way plants grow --- and harvests the molecules they build.